Literature DB >> 6899978

Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.

R D Schreiber, M K Pangburn, R G Medicus, H J Müller-Eberhard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6899978     DOI： 10.1016/0090-1229(80)90050-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  16 in total

1.  Reduced activity of DAF on complement enzymes bound to alternative pathway activators. Similarity with Factor H.

Authors:  M K Pangburn
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

2.  Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.

Authors:  V Vĕtvicka; M Hanikýrová; J Vĕtvicková; G D Ross
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

3.  Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.

Authors:  D E Martin; F J Chiu; I Gigli; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

Review 4.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction.

Authors:  B A Blazar; J Fitzgerald; L Sutton; M Strome
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

6.  Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.

Authors:  O F Ramos; G Sármay; E Klein; E Yefenof; J Gergely
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors:  G R Nemerow; F C Jensen; N R Cooper
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.